All Stories

  1. The German Federal Supreme Court also granted a compulsory patent license for the first time in its history

    Article • Pharmaceutical Patent Analyst, November 2017, Future Science

    Dr Takeshi S. Komatani

  2. Doctrine of equivalents in Japan – criteria of special conditions and estoppel: final conclusion

    Article • Pharmaceutical Patent Analyst, November 2017, Future Science

    Dr Takeshi S. Komatani

  3. January 2017 extended scope of patent term extension: Japan is progenerics Debiopharm – International SA vs Towa Pharmaceutical Co. Ltd

    Article • Pharmaceutical Patent Analyst, May 2017, Future Science

    Dr Takeshi S. Komatani

  4. Is inherent disclosure sufficient for priority claim? Monoclonal versus chimeric/humanized antibody: estoppels

    Article • Pharmaceutical Patent Analyst, November 2016, Future Science

    Dr Takeshi S. Komatani

  5. Pharmaceutical patent law: expert perspectives from around the globe

    Article • Pharmaceutical Patent Analyst, July 2016, Future Science

    Dr Takeshi S. Komatani

  6. Patent and intellectual property rights related to pharmaceuticals: global future perspectives: Japan

    Article • Pharmaceutical Patent Analyst, July 2016, Future Science

    Dr Takeshi S. Komatani

  7. Doctrine of equivalents in Japan: criteria of special conditions and estoppel

    Article • Pharmaceutical Patent Analyst, May 2016, Future Science

    Dr Takeshi S. Komatani

  8. November 2015: patent term extension: the Supreme Court of Japan gave an answer to the question and the JPO now has to prepare new examination guidelines

    Article • Pharmaceutical Patent Analyst, May 2016, Future Science

    Dr Takeshi S. Komatani

  9. Patenting drug delivery technology: tips for formulating practical and effective patent portfolio

    Article • Pharmaceutical Patent Analyst, March 2016, Future Science

    Dr Takeshi S. Komatani

  10. Product by process or PBP patent claims

    Article • Pharmaceutical Patent Analyst, November 2015, Future Science

    Dr Takeshi S. Komatani

  11. Patent protection of diagnostic technology: will recent US Supreme Court decisions change patent strategy?

    Article • Pharmaceutical Patent Analyst, September 2015, Future Science

    Dr Takeshi S. Komatani

  12. Intellectual property protection of molecules/proteins/genes/natural products: will recent case law change patent practice in the pharmaceutical industry?

    Article • Pharmaceutical Patent Analyst, May 2015, Future Science

    Dr Takeshi S. Komatani

  13. Cases Update

    Article • Pharmaceutical Patent Analyst, January 2015, Future Science

    Dr Takeshi S. Komatani

  14. Scope of protection of a patent directed to prodrugs, metabolites and the like

    Article • Pharmaceutical Patent Analyst, November 2014, Future Science

    Dr Takeshi S. Komatani

  15. Cases update: international roundup of recently filed cases and noteworthy rulings

    Article • Pharmaceutical Patent Analyst, November 2014, Future Science

    Dr Takeshi S. Komatani

  16. Intellectual property strategy for regenerative medicine: is it time to ‘regenerate’?

    Article • Pharmaceutical Patent Analyst, September 2014, Future Science

    Dr Takeshi S. Komatani

  17. Cases Update

    Article • Pharmaceutical Patent Analyst, July 2014, Future Science

    Dr Takeshi S. Komatani

  18. Changes in global pharmaceutical patent strategy due to intergovernmental cooperation

    Article • Pharmaceutical Patent Analyst, March 2014, Future Science

    Dr Takeshi S. Komatani

  19. Cases Update: International roundup of recently filed cases and noteworthy rulings

    Article • Pharmaceutical Patent Analyst, March 2014, Future Science

    Dr Takeshi S. Komatani

  20. Cases Update

    Article • Pharmaceutical Patent Analyst, January 2014, Future Science

    Dr Takeshi S. Komatani

  21. Cases Update: International roundup of recently filed cases and noteworthy rulings

    Article • Pharmaceutical Patent Analyst, November 2013, Future Science

    Dr Takeshi S. Komatani

  22. Cases Update: International roundup of recently filed cases and noteworthy rulings

    Article • Pharmaceutical Patent Analyst, September 2013, Future Science

    Dr Takeshi S. Komatani

  23. Cases Update

    Article • Pharmaceutical Patent Analyst, July 2013, Future Science

    Dr Takeshi S. Komatani

  24. Association of University Technology Managers Asia 2013 conference

    Article • Pharmaceutical Patent Analyst, July 2013, Future Science

    Dr Takeshi S. Komatani

  25. Cases Update

    Article • Pharmaceutical Patent Analyst, May 2013, Future Science

    Dr Takeshi S. Komatani

  26. Challenges to obtaining good pharmaceutical patents in Japan: 2009 and beyond

    Article • Pharmaceutical Patent Analyst, May 2013, Future Science

    Dr Takeshi S. Komatani

  27. Cases Update

    Article • Pharmaceutical Patent Analyst, March 2013, Future Science

    Dr Takeshi S. Komatani

  28. Cases Update

    Article • Pharmaceutical Patent Analyst, January 2013, Future Science

    Dr Takeshi S. Komatani

  29. Patent term extension in Japan: challenges still lay ahead even after the 2011 revision

    Article • Pharmaceutical Patent Analyst, January 2013, Future Science

    Dr Takeshi S. Komatani

  30. Cases Update

    Article • Pharmaceutical Patent Analyst, November 2012, Future Science

    Dr Takeshi S. Komatani

  31. Cases Update

    Article • Pharmaceutical Patent Analyst, September 2012, Future Science

    Dr Takeshi S. Komatani